PL374762A1 - Estrogen replacement regimen - Google Patents

Estrogen replacement regimen

Info

Publication number
PL374762A1
PL374762A1 PL03374762A PL37476203A PL374762A1 PL 374762 A1 PL374762 A1 PL 374762A1 PL 03374762 A PL03374762 A PL 03374762A PL 37476203 A PL37476203 A PL 37476203A PL 374762 A1 PL374762 A1 PL 374762A1
Authority
PL
Poland
Prior art keywords
estrogen replacement
replacement regimen
regimen
estrogen
dose estradiol
Prior art date
Application number
PL03374762A
Other languages
English (en)
Polish (pl)
Inventor
Robert Casper
Gideon Kopernik
Zeev Shoham
Original Assignee
Robert Casper
Gideon Kopernik
Zeev Shoham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert Casper, Gideon Kopernik, Zeev Shoham filed Critical Robert Casper
Publication of PL374762A1 publication Critical patent/PL374762A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL03374762A 2002-08-28 2003-08-28 Estrogen replacement regimen PL374762A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40633102P 2002-08-28 2002-08-28

Publications (1)

Publication Number Publication Date
PL374762A1 true PL374762A1 (en) 2005-10-31

Family

ID=31978284

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03374762A PL374762A1 (en) 2002-08-28 2003-08-28 Estrogen replacement regimen

Country Status (25)

Country Link
US (1) US8946198B2 (enExample)
EP (1) EP1539184B1 (enExample)
JP (1) JP2005538150A (enExample)
KR (1) KR20050059092A (enExample)
CN (1) CN1678324A (enExample)
AT (1) ATE345804T1 (enExample)
AU (1) AU2003264203A1 (enExample)
BR (1) BR0313921A (enExample)
CA (1) CA2495330A1 (enExample)
CY (1) CY1106019T1 (enExample)
DE (1) DE60309895T2 (enExample)
DK (1) DK1539184T3 (enExample)
ES (1) ES2277139T3 (enExample)
HR (1) HRP20050291A2 (enExample)
IL (1) IL166585A0 (enExample)
MX (1) MXPA05002294A (enExample)
NO (1) NO20051545L (enExample)
NZ (1) NZ538342A (enExample)
PL (1) PL374762A1 (enExample)
PT (1) PT1539184E (enExample)
RS (1) RS20050184A (enExample)
RU (1) RU2340345C2 (enExample)
UA (1) UA82851C2 (enExample)
WO (1) WO2004019954A1 (enExample)
ZA (1) ZA200501274B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
DE102009007771B4 (de) 2009-02-05 2012-02-16 Bayer Schering Pharma Aktiengesellschaft Bukkales Applikationssystem, 17α-Estradiol enthaltend
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015229421B2 (en) * 2014-03-12 2020-06-04 Allergan Therapeutics LLC Low-dose estradiol cream
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
JP6866561B2 (ja) 2015-06-18 2021-04-28 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロールを含有する口腔内崩壊錠
HRP20200850T1 (hr) 2015-06-18 2020-10-02 Estetra Sprl Orodisperzibilna jedinica za doziranje koja sadrži komponentu estetrola
EP3106148B1 (en) 2015-06-18 2018-03-14 Mithra Pharmaceuticals S.A. Orodispersible dosage unit containing an estetrol component
HUE054551T2 (hu) 2015-06-18 2021-09-28 Estetra Sprl Ösztetrolt tartalmazó, szájban diszpergálódó tabletta
MX2017016823A (es) 2015-06-22 2018-03-12 Lipocine Inc Composiciones orales que contienen éster de 17- hydroxiprogesterona y métodos relacionados.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
KR102712911B1 (ko) 2016-08-05 2024-10-04 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
ATE86484T1 (de) 1987-08-08 1993-03-15 Akzo Nv Kontrazeptives implantat.
US4900734A (en) * 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
US5256421A (en) 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
FI101601B1 (fi) * 1987-09-24 1998-07-31 Jencap Research Ltd Ehkäisyvalmiste sekä estrogeenin ja progestiinin käyttö ehkäisyvalmisteen valmistusmenetelmässä
US5108995A (en) 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5422119A (en) 1987-09-24 1995-06-06 Jencap Research Ltd. Transdermal hormone replacement therapy
US5382873A (en) 1991-12-04 1995-01-17 U.S. Philips Corporation High-pressure discharge lamp with incandescing metal droplets
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
HU228434B1 (en) * 1995-06-07 2013-03-28 Ortho Mcneil Pharm Inc Transdermal medicament for administering 17-deacetyl norgestimate alone or in combination with an estrogen
US6506390B2 (en) * 1996-06-25 2003-01-14 Akzo Nobel Progestogen-anti-progestogen regimens
CA2267743C (en) * 1999-03-30 2011-07-26 Robert F. Casper Low dose estrogen interrupted hormone replacement therapy
US6653298B2 (en) * 2000-01-14 2003-11-25 Sterix Limited Composition
DE10100911A1 (de) * 2001-01-11 2002-08-01 Schering Ag Verfahren zur Hormonersatztherapie und dessen Darreichungsform

Also Published As

Publication number Publication date
MXPA05002294A (es) 2005-09-12
CN1678324A (zh) 2005-10-05
NZ538342A (en) 2007-08-31
US8946198B2 (en) 2015-02-03
DE60309895T2 (de) 2007-10-18
ES2277139T3 (es) 2007-07-01
US20060089337A1 (en) 2006-04-27
DK1539184T3 (da) 2007-03-19
BR0313921A (pt) 2005-07-19
JP2005538150A (ja) 2005-12-15
IL166585A0 (en) 2006-01-15
EP1539184A1 (en) 2005-06-15
DE60309895D1 (de) 2007-01-04
RU2340345C2 (ru) 2008-12-10
PT1539184E (pt) 2007-02-28
HRP20050291A2 (en) 2005-10-31
CA2495330A1 (en) 2004-03-11
EP1539184B1 (en) 2006-11-22
CY1106019T1 (el) 2011-04-06
WO2004019954A1 (en) 2004-03-11
NO20051545L (no) 2005-03-23
KR20050059092A (ko) 2005-06-17
UA82851C2 (en) 2008-05-26
RS20050184A (sr) 2007-11-15
RU2005108977A (ru) 2005-10-10
ATE345804T1 (de) 2006-12-15
AU2003264203A1 (en) 2004-03-19
ZA200501274B (en) 2006-08-30

Similar Documents

Publication Publication Date Title
HRP20050291A2 (en) Estrogen replacement regimen
IL175158A0 (en) Tocopherol-modified therapeutic drug compounds
MY126960A (en) Administration of non-oral androgenic steroids to women
IL153297A0 (en) Compounds and compositions for delivering active agents
BG106738A (en) A method for chemoprevention of prostate cancer
ATE202281T1 (de) Hormon-ersatztherapie
SG153645A1 (en) Hormone replacement therapy
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
PL356846A1 (en) Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase
IL146125A0 (en) Novel quinones as disease therapies
MY137766A (en) Exemestane as chemopreventing agent
PT1526856E (pt) Composição farmacêutica que compreende derivados do estretol para ser utilizada no tratamento do cancro
NO20040598L (no) 5-CNAC som oralt avleveringsmiddel for paratyreoidhormonfragmenter.
PT986573E (pt) Derivados nao estrogenicos do estradiol com actividade antioxidante
EA200301023A1 (ru) Заместительная терапия эстрогенами
EA200200943A1 (ru) Гормональная терапия рака молочной железы
PE20010680A1 (es) Uso de lasofoxifeno
TW200503731A (en) Method of treatment
BR0310085A (pt) Terapia de substituição de hormÈnio
WO2002074315A8 (de) Pharmazeutische kombinationspräparate enthaltend aromatasehemmer und substanzen mit estrogener wirkung sowie ihre verwendung zur herstellung eines medikaments zur estrogen-ersatz-therapie
TW200503783A (en) Oral pharmaceutical preparation for proton pump antagonists
BR0311184A (pt) Terapia de reposição de hormÈnio
PL1635843T3 (pl) Hormonalna terapia zastępcza i leczenie depresji obejmujące dienogest
PT1713438E (pt) Sabonete medicinal
MXPA04003781A (es) Uso de (11b, 17b)-11 -(1, 3-benzodioxol-5-il) -17-hidroxi -17-(1-propinil) -estra-4, 9-dieno-3 -ona en el tratamiento de un padecimiento depresivo mayor.

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)